SpringWorks Therapeutics, Inc. (NasdaqGS: SWTX) Loss Submission Form

Kuznicki Law is investigating the proposed sale of SpringWorks Therapeutics, Inc. (NasdaqGS: SWTX) to Merck KGaA, Darmstadt, Germany. Under the terms of the proposed transaction, shareholders of SpringWorks will receive $47.00 in cash for each share of SpringWorks that they own. The firm is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.